This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Stuart Yudofsky, MD; Jonathan M. Silver, MD
New York State Psychiatric Institute 722 W 168th St New York, NY 10032

Arch Gen Psychiatry. 1984;41(12):1185-1186.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Two recent articles have reported on the use of β-adrenergic blocking agents in the treatment of panic disorder. Gorman et al¹ reported on the effects of intravenously (IV) administered propranolol hydrochloride in lactate-induced panic in patients with preexisting panic disorders, and Noyes et al² compared the efficacy of diazepam with propranolol in the treatment of patients who had panic disorder and agoraphobia. Gorman et al¹ found that pretreatment with IV-administered propranolol failed to prevent panic attacks in any of the six patients who received a lactate infusion, and Noyes et al reported that "propranolol did not reduce the number and severity of panic attacks."²

It is our opinion that two major considerations in evaluating the efficacy of β-blocking agents in the treatment of behavioral and emotional disorders are dose and duration of treatment. Our group has been investigating the efficacy of propranolol in . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?